Credit: Neurovalens. Modius Sleep is an electrical vestibular nerve stimulator that sends signals to a neural pathway that connects to the hypothalamus. Modius Sleep lowered Insomnia Severity Index by ...

Neurovalens successfully secured 510(k) clearance from the FDA on October 27, 2023 for its Modius Sleep device with relation to treatment of insomnia and/or anxiety. The clearance was supported by ...

People suffering from chronic insomnia now have a new, drug-free option to treat the condition in the U.S. The FDA doled out a clearance to Neurovalens’ Modius Sleep device, which relies on ...

95 percent of clinical trial participants reported better sleep in four weeks BELFAST, Northern Ireland, Oct. 28, 2024 /PRNewswire/ -- Neurovalens, a global health-tech leader in neurotechnology, has ...

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurovalens, a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today launches its Modius SLEEP ...

Based in Belfast, Neurovalens, a global leader in non-invasive neuro-technology, is a pioneering medical device company which specialises in leveraging the power of neuroscience and advanced ...

A headset for treatment of insomnia which was developed by a company in Belfast has been approved for sale in Europe and the UK. The Modius Sleep from Neurovalens has now achieved EU Medical Device ...

Belfast-based Neurovalens, a global leader in non-invasive neuro-technology, has received medical device clearance from the US Food & Drug Administration (FDA) to treat chronic insomnia with its ...

Belfast-based medtech firm Neurovalens has secured approval to sell its device for treating insomnia in the EU and UK. The company’s Modius technology uses low-level electrical signals to stimulate ...

Belfast-based neurotechnology company Neurovalens has received approval for its prescribed insomnia treatment from authorities in the European Union (EU) and the UK, clearing the way for its sale in ...